Astragalus membranaceus

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Astralagus

Theory[edit | edit source]

Evidence[edit | edit source]

Clinicians[edit | edit source]

Risks and safety[edit | edit source]

Costs and availability[edit | edit source]

Equilibrant[edit | edit source]

Astragalus is an ingredient in equilibrant, a supplement developed for patients with ME/CFS.

Immune system[edit | edit source]

  • 1990, Effect of Astragulas membranaceus on natural killer cell activity and induction of alpha- and gamma-interferon in patients with Coxsackie B viral myocarditis.[1]
  • 2009, Astragalus membranaceus flavonoids (AMF) ameliorate chronic fatigue syndrome induced by food intake restriction plus forced swimming[2]

References[edit | edit source]

  1. Yz, Yang; Py, Jin; Q, Gúo; Qd, Wang; Zs, Li; Yc, Ye; Yf, Shan; Hy, Zhao; Jr, Zhu; Sy, Pu (1990), "Effect of Astragulas membranaceus on natural killer cell activity and induction of alpha- and gamma-interferon in patients with Coxsackie B viral myocarditis.", Chinese medical journal, 103 (4): 304–307, ISSN 0366-6999, PMID 2167822, retrieved November 9, 2016
  2. Kuo, Yao-Haur; Tsai, Wei-Jern; Loke, Soy-Hwee; Wu, Tian-Shung; Chiou, Wen-Fei (February 2009). "Astragalus membranaceus flavonoids (AMF) ameliorate chronic fatigue syndrome induced by food intake restriction plus forced swimming". Journal of Ethnopharmacology. 122 (1): 28–34. doi:10.1016/j.jep.2008.11.025. ISSN 0378-8741.